The latest financial statement is for the quarter ending 2026-03-31.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Gain on disposition of discontinued operations | - | 5,263,400 | - | - |
| Provision for bad debt | - | 7,300 | 0 | 0 |
| Net loss | -1,589,300 | -1,220,400 | - | - |
| Net income (loss) | - | - | 3,994,400 | -3,302,200 |
| Less income from discontinued operations, net of tax | 0 | -1,119,800 | 559,900 | - |
| Loss from continuing operations | -1,589,300 | -1,780,300 | - | - |
| Provision for inventory reserves | - | -757,400 | - | - |
| Net income (loss) from continuing operations | - | - | 132,300 | - |
| Gain on sale of genie product line | - | - | 5,263,400 | - |
| Depreciation and amortization | 55,300 | 151,800 | 137,200 | 321,000 |
| Impairment of intangible assets | - | 291,600 | - | - |
| Stock-based compensation | 116,300 | 72,600 | 72,900 | 375,200 |
| Gain on sale of investment securities | 0 | 3,700 | -3,700 | 20,100 |
| Unrealized holding loss (gain) on investment securities | -19,900 | -13,900 | 2,900 | 8,600 |
| Noncash lease expense | 79,700 | 71,100 | 84,400 | 101,600 |
| Trade accounts receivable | -330,500 | 846,100 | -295,000 | -259,900 |
| Inventories | 207,000 | 660,100 | -125,700 | 147,700 |
| Prepaid and other current assets | -234,600 | 463,000 | 201,700 | 126,400 |
| Income tax receivable | - | 0 | 0 | 0 |
| Other assets | 100 | -29,100 | 8,600 | -4,300 |
| Accounts payable | -43,600 | 245,600 | -115,200 | 36,000 |
| Contract liabilities | - | 36,300 | 0 | 0 |
| Accrued expenses | 93,600 | 48,100 | -111,000 | -149,500 |
| Lease liabilities | -83,400 | -74,800 | -87,000 | -106,400 |
| Net cash used in operating activities | -993,500 | -3,758,900 | -1,627,800 | -2,762,900 |
| Purchases of investment securities | 75,900 | 242,500 | 7,223,200 | 0 |
| Redemption of investment securities | 896,000 | 1,648,800 | 483,000 | 1,613,900 |
| Proceeds from gain on sale of genie product line | - | - | 7,614,200 | - |
| Proceeds from disposition of discontinued operations | - | 7,614,200 | - | - |
| Capital expenditures | 6,200 | 19,600 | 10,400 | 33,200 |
| Net cash provided by investing activities | 813,900 | 1,386,700 | 863,600 | 1,580,700 |
| Proceeds from issuance of common stock | - | -100 | 500,100 | 1,550,000 |
| Issuance costs of common stock and warrants | - | - | - | -97,800 |
| Issuance cost of common stock and warrants | - | 0 | 97,800 | - |
| Net cash provided by financing activities | - | -100 | 500,100 | 1,452,200 |
| Net cash provided by (used in) operating activities of discontinued operations | - | 2,165,100 | 529,700 | - |
| Net cash provided by discontinued operations | -460,500 | - | 529,700 | - |
| Net change in cash and cash equivalents | -110,400 | - | - | - |
| Effect of changes in foreign currency exchange rates on cash and cash equivalents | -46,800 | -400 | 5,600 | 33,500 |
| Net decrease in cash and cash equivalents | -157,200 | -207,200 | 232,100 | 303,500 |
| Cash and cash equivalents, beginning of period | 955,000 | 1,162,600 | 587,900 | - |
| Cash from discontinued operations beginning of year | - | 1,162,600 | - | - |
| Less cash from discontinued operations end of year | - | 0 | - | - |
| Cash and cash equivalents, end of period | 797,800 | 955,000 | 1,162,600 | - |
SCIENTIFIC INDUSTRIES INC (SCND)
SCIENTIFIC INDUSTRIES INC (SCND)